PubRank

J M Pellock

Author PubWeight™ 60.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phenomenology of prolonged febrile seizures: results of the FEBSTAT study. Neurology 2008 3.83
2 Determinants of mortality in status epilepticus. Epilepsia 1994 3.03
3 A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998 2.82
4 A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996 2.69
5 Epidemiology of status epilepticus. J Clin Neurophysiol 1995 2.48
6 Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999 2.29
7 Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004 2.19
8 Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol 1977 1.90
9 Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988 1.71
10 Utility of electroencephalography in the pediatric emergency department. J Child Neurol 2001 1.44
11 In whom does status epilepticus occur: age-related differences in children. Epilepsia 1997 1.26
12 Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994 1.16
13 Status epilepticus in children, adults, and the elderly. Epilepsia 1992 1.12
14 Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2001 0.97
15 Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res 2000 0.97
16 Rectal diazepam gel for treatment of acute repetitive seizures. The North American Diastat Study Group. Pediatr Neurol 1999 0.96
17 Univariate genetic analyses of epilepsy and seizures in a population-based twin study: the Virginia Twin Registry. Genet Epidemiol 1998 0.95
18 Short-term outcomes of children with febrile status epilepticus. Epilepsia 2001 0.92
19 The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins. Neurology 1991 0.90
20 Encephalopathy as the presenting symptom of Hashimoto's thyroiditis. J Child Neurol 2000 0.89
21 The occurrence and characteristics of auras in a large epilepsy cohort. Acta Neurol Scand 2008 0.89
22 Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res 1998 0.89
23 Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin. Epilepsy Res 1997 0.88
24 Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res 1992 0.87
25 Kearns-Sayre syndrome and hypoparathyroidism. Ann Neurol 1978 0.87
26 A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991 0.86
27 New drug therapy for acute seizure management. Semin Pediatr Neurol 1997 0.85
28 Safety of intravenous valproate. Ann Neurol 1995 0.84
29 A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology 1999 0.83
30 Characterization of seizures associated with biotinidase deficiency. Neurology 1993 0.83
31 Postictal pulmonary edema in children. Neurology 1985 0.83
32 Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery. Arch Neurol 1996 0.82
33 Discordant expression of fetal hydantoin syndrome in heteropaternal dizygotic twins. N Engl J Med 1982 0.81
34 Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy. Epilepsia 1998 0.81
35 Evidence for a genetic predisposition for status epilepticus. Neurology 1998 0.81
36 Epilepsy and seizure occurrence in a population-based sample of Virginian twins and their families. Epilepsy Res 1999 0.80
37 Meralgia paraesthetica in a child. J Pediatr 1978 0.80
38 Felbamate: 1997 update. Epilepsia 1997 0.80
39 Kearns-Sayre syndrome or ophthalmoplegia-plus? To lump or to split? Trans Am Neurol Assoc 1976 0.79
40 Taming the brain storms: felbamate updated. Lancet 1995 0.78
41 Effect of antacids on phenytoin bioavailability. Ther Drug Monit 1981 0.77
42 Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. Neurology 1994 0.77
43 Effects of food on valproic acid absorption. Am J Hosp Pharm 1981 0.77
44 Effects of three antacids on the bioavailability of valproic acid. Clin Pharm 1983 0.77
45 Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 2004 0.76
46 Treatment of absence status with intravenous valproate. Neurology 1999 0.76
47 Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations. Acta Neurol Scand Suppl 2011 0.76
48 Valproate toxicity: risk-screening strategies. J Child Neurol 1991 0.76
49 Lamotrigine. J Child Neurol 1997 0.76
50 A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment. Seizure 2002 0.75
51 Pyridoxine deficiency in children treated with isoniazid. Chest 1985 0.75
52 Carnitine deficiency. Pediatrics 1995 0.75
53 'Respiratory depression in children receiving diazepam for acute seizures: a prospective study'. Dev Med Child Neurol 2000 0.75
54 Effect of calcium and antacids on phenytoin bioavailability. Arch Neurol 1980 0.75
55 Pediatric epilepsy in the 1990s. Semin Pediatr Neurol 1997 0.75
56 Overview of childhood epilepsy and epileptic syndromes and advances in therapy. Curr Pharm Des 2000 0.75
57 The prevalence of smoking among adolescents with primary tuberculosis. Chest 1974 0.75
58 Influence of tube type, storage time, and temperature on the total and free concentration of valproic acid. Ther Drug Monit 1986 0.75
59 Effects of exercise on valproic acid pharmacokinetics. Clin Pharm 1983 0.75
60 Recent developments in the treatment of epilepsy: diagnosis and treatment. Del Med J 1981 0.75
61 Single dose comparison of the relative bioavailability of phenytoin suspension and extended capsules. Epilepsia 1986 0.75
62 Phenytoin-associated thrombocytopenia in a toddler. J Child Neurol 1999 0.75
63 Risk-benefit assessment of carbamazepine in children. Drug Saf 1991 0.75
64 Childhood hypertensive stroke with neurofibromatosis. Neurology 1980 0.75
65 Treatment of seizures in childhood. Va Med 1988 0.75
66 Diagnosis and treatment of epilepsy in children and adolescents. Drugs 1996 0.75
67 New antiepileptic drugs: case studies. Semin Pediatr Neurol 1997 0.75
68 The challenge of treatment selection for epilepsy. Epilepsia 2001 0.75
69 Occipital encephalocele--a case of conjoined twinning? Neurosurgery 1983 0.75
70 Who should receive prophylactic antiepileptic drug following head injury? Brain Inj 1989 0.75
71 Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailability. Epilepsia 1988 0.75
72 Usefulness of a single-dose prediction model for the determination of long-term maintenance therapy of valproic acid. Ther Drug Monit 1989 0.75
73 A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation. Ther Drug Monit 1987 0.75
74 Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients. Clin Pharm 1985 0.75
75 Periventricular leukomalacia related to neonatal anoxia: recognition by computed tomography. J Comput Assist Tomogr 1978 0.75
76 Recent developments in the treatment of epilepsy, part II: modern therapeutic methods. Del Med J 1981 0.75